Literature DB >> 19891650

Rat allogeneic mesenchymal stem cells did not prolong the survival of corneal xenograft in a pig-to-rat model.

Joo Youn Oh1, Mee Kum Kim, Jung Hwa Ko, Hyun Ju Lee, Jin Hak Lee, Won Ryang Wee.   

Abstract

OBJECTIVE: Recent reports have demonstrated that mesenchymal stem cells (MSCs) can modulate/suppress immunologic responses through interactions with different immune cells. We performed this study in order to investigate the immunomodulatory effects of MSCs in corneal xenotransplantation. ANIMALS STUDIED: Pig and rat. PROCEDURES: We orthotopically transplanted pig corneas into rats and topically applied allogeneic rat MSCs to the corneas for 2 h immediately after transplantation. Graft survival was clinically assessed using slit-lamp biomicroscopy and the median survival time (MST) was calculated. The rejected grafts were histologically examined using antibodies against CD4, CD8, CD161, and CD68. The expression of IL-2, IL-6, IL-10, and IFN-gamma was also evaluated in the rejected grafts using an enzyme-linked immunosorbent assay.
RESULTS: The survival of corneal xenografts was not significantly prolonged by MSC application (MST 10.5 days) compared with the controls (MST 9.67 days) (P = 0.4189). Histologically, the rejected grafts in both groups were massively infiltrated with neutrophils and macrophages. Some CD8+ T cells and rare NK cells were found in the rejected grafts. The levels of IL-6 and IL-10 were significantly increased in the rejected grafts from MSC-treated rats compared with the grafts from MSC-untreated rats. However, the levels of IL-2 and IFN-gamma were not different between the two groups.
CONCLUSIONS: Topical application of allogeneic rat MSCs was ineffective in prolonging corneal xenograft survival in a pig-to-rat model.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19891650     DOI: 10.1111/j.1463-5224.2009.00724.x

Source DB:  PubMed          Journal:  Vet Ophthalmol        ISSN: 1463-5216            Impact factor:   1.644


  6 in total

Review 1.  Mesenchymal stem cells: Potential role in corneal wound repair and transplantation.

Authors:  Fei Li; Shao-Zhen Zhao
Journal:  World J Stem Cells       Date:  2014-07-26       Impact factor: 5.326

2.  Adipose-derived mesenchymal stem cell administration does not improve corneal graft survival outcome.

Authors:  Sherezade Fuentes-Julián; Francisco Arnalich-Montiel; Laia Jaumandreu; Marina Leal; Alfonso Casado; Ignacio García-Tuñon; Enrique Hernández-Jiménez; Eduardo López-Collazo; Maria P De Miguel
Journal:  PLoS One       Date:  2015-03-02       Impact factor: 3.240

3.  Biodistribution and Immunogenicity of Allogeneic Mesenchymal Stem Cells in a Rat Model of Intraarticular Chondrocyte Xenotransplantation.

Authors:  Maribel Marquina; Javier A Collado; Magdiel Pérez-Cruz; Pablo Fernández-Pernas; Juan Fafián-Labora; Francisco J Blanco; Rafael Máñez; María C Arufe; Cristina Costa
Journal:  Front Immunol       Date:  2017-11-06       Impact factor: 7.561

4.  Priming Mesenchymal Stem Cells with Endothelial Growth Medium Boosts Stem Cell Therapy for Systemic Arterial Hypertension.

Authors:  Lucas Felipe de Oliveira; Thalles Ramos Almeida; Marcus Paulo Ribeiro Machado; Marilia Beatriz Cuba; Angélica Cristina Alves; Marcos Vinícius da Silva; Virmondes Rodrigues Júnior; Valdo José Dias da Silva
Journal:  Stem Cells Int       Date:  2015-08-02       Impact factor: 5.443

Review 5.  Review: mesenchymal stem cells and corneal reconstruction.

Authors:  Lin Yao; Haiqing Bai
Journal:  Mol Vis       Date:  2013-11-07       Impact factor: 2.367

Review 6.  Control of Cross Talk between Angiogenesis and Inflammation by Mesenchymal Stem Cells for the Treatment of Ocular Surface Diseases.

Authors:  Fei Li; Shao-Zhen Zhao
Journal:  Stem Cells Int       Date:  2016-03-24       Impact factor: 5.443

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.